Videos

Anne M. Suskind, MD, MS, discusses the findings of the recent study, published in Urology.

Meena Davuluri, MD, MPH, and Kara L. Watts, MD, discuss findings from a study published in Urology Practice.

Ranjith Ramasamy, MD, discusses a recent study evaluating the testosterone nasal gel Natesto.

Andrew J. Cohen, MD, discusses a recent study evaluating treatment of urethral stricture disease in the US.

Amanda North, MD, outlines finding from a paper recently published in Urology Practice.

Julia Beth Finkelstein, MD, MPH, CPPS, and colleagues evaluated the safety and costs associated with telemedicine appointments for pediatric urologic patients.

In this interview, Jeffrey Weiss, MD, also describes “most exciting area in nocturia research.”

In this interview, Gopal H. Badlani speaks to Jeffrey P. Weiss, MD, regarding how Weiss defines nocturia and separating the symptom from overactive bladder.

In this video, Eric Klein, MD, discusses a study evaluating the 17-gene Oncotype DX Genomic Prostate Score assay in African American and Caucasian American men.

Kevin McVary, MD, of Loyola University Medical Center in Maywood, IL, provides urologists with tips on how to assess the adoptability of minimally invasive surgical therapies for BPH.

In this video, Scott Eggener, MD, outlines which patients are the best candidates for focal therapy for prostate cancer, and discusses the differences in follow-up for patients treated with focal therapy compared with those undergoing active surveillance.

Martin Gleave, MD, of the University of British Columbia in Vancouver, discusses the Genomic Umbrella Neoadjuvant Study (GUNS) trial, which uses a multi-arm, multistage adaptive design to test targeted therapies in patients with high-risk localized disease by matching neoadjuvant therapies to baseline genomic alterations.

LUGPA President Dr. Harris discusses legislative/policy challenges in 2020.